Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (2): 165-173.DOI: 10.3969/j.issn.1673-8640.2022.02.015
Previous Articles Next Articles
LU Youli, YANG Shuangshuang, ZHANG Meiwei, OU Meixian, DONG Chunxia, SHEN Weiwei, JIANG Fengli, LI Shuijun()
Received:
2021-07-02
Revised:
2021-08-29
Online:
2022-02-28
Published:
2022-03-15
Contact:
LI Shuijun
CLC Number:
LU Youli, YANG Shuangshuang, ZHANG Meiwei, OU Meixian, DONG Chunxia, SHEN Weiwei, JIANG Fengli, LI Shuijun. Simultaneous determination of 5 steroid hormones in human serum by ultra-performance liquid chromatography-tandem mass spectrometry and establishment of reference intervals in healthy adults[J]. Laboratory Medicine, 2022, 37(2): 165-173.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.02.015
分析物 | 标准曲线添加液 | 质控添加液 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
S1 | S2 | S3 | S4 | S5 | S6 | 低浓度 | 中浓度 | 高浓度 | ||
T、AD、17OHP | 1 | 2 | 10 | 50 | 250 | 1 000 | 3 | 25 | 800 | |
DHT | 2 | 4 | 20 | 100 | 500 | 2 000 | 6 | 50 | 1 600 | |
DHEA | 10 | 20 | 100 | 500 | 2 500 | 10 000 | 30 | 250 | 8 000 |
分析物 | 标准曲线添加液 | 质控添加液 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
S1 | S2 | S3 | S4 | S5 | S6 | 低浓度 | 中浓度 | 高浓度 | ||
T、AD、17OHP | 1 | 2 | 10 | 50 | 250 | 1 000 | 3 | 25 | 800 | |
DHT | 2 | 4 | 20 | 100 | 500 | 2 000 | 6 | 50 | 1 600 | |
DHEA | 10 | 20 | 100 | 500 | 2 500 | 10 000 | 30 | 250 | 8 000 |
分析物名称 | 监测离子对/(m/z) | 碰撞能量/eV | 监测方式 | 内标 |
---|---|---|---|---|
T | 289.2①/97.0②/109.0③ | 31/35 | + | T-d3 |
DHT | 291.2①/255.2②/159.0③ | 21/31 | + | DHT-d3 |
AD | 287.2①/97.0②/109.0③ | 30/33 | + | AD-13C3 |
DHEA | 289.2①/253.2②/213.1③ | 16/26 | + | DHEA-d5 |
17OHP | 331.2①/97.0②/109.0③ | 33/33 | + | 17OHP-d8 |
T-d3 | 292.2①/97.0② | 31 | + | 无 |
DHT-d3 | 294.2①/258.2② | 21 | + | 无 |
AD-13C3 | 290.2①/100.0② | 30 | + | 无 |
DHEA-d5 | 294.3①/258.2② | 16 | + | 无 |
17OHP-d8 | 339.2①/100.0② | 33 | + | 无 |
分析物名称 | 监测离子对/(m/z) | 碰撞能量/eV | 监测方式 | 内标 |
---|---|---|---|---|
T | 289.2①/97.0②/109.0③ | 31/35 | + | T-d3 |
DHT | 291.2①/255.2②/159.0③ | 21/31 | + | DHT-d3 |
AD | 287.2①/97.0②/109.0③ | 30/33 | + | AD-13C3 |
DHEA | 289.2①/253.2②/213.1③ | 16/26 | + | DHEA-d5 |
17OHP | 331.2①/97.0②/109.0③ | 33/33 | + | 17OHP-d8 |
T-d3 | 292.2①/97.0② | 31 | + | 无 |
DHT-d3 | 294.2①/258.2② | 21 | + | 无 |
AD-13C3 | 290.2①/100.0② | 30 | + | 无 |
DHEA-d5 | 294.3①/258.2② | 16 | + | 无 |
17OHP-d8 | 339.2①/100.0② | 33 | + | 无 |
添加浓度/(ng/mL) | 批内 | 批间 | |||
---|---|---|---|---|---|
精密度(CV)/% | 准确度/% | 精密度(CV)/% | 准确度/% | ||
T | |||||
0.03 | 3.43 | 102.8 | 2.91 | 100.9 | |
0.25 | 4.12 | 101.1 | 3.64 | 100.7 | |
8.00 | 2.30 | 97.4 | 3.01 | 97.1 | |
DHT | |||||
0.06 | 2.92 | 101.9 | 3.56 | 100.5 | |
0.50 | 3.22 | 104.8 | 3.49 | 105.2 | |
16.00 | 2.53 | 100.4 | 2.87 | 102.4 | |
AD | |||||
0.03 | 2.62 | 99.2 | 4.47 | 99.6 | |
0.25 | 3.54 | 99.8 | 3.57 | 101.4 | |
8.00 | 2.59 | 104.2 | 2.97 | 102.3 | |
DHEA | |||||
0.30 | 4.75 | 101.8 | 4.75 | 98.2 | |
2.50 | 3.08 | 101.7 | 5.33 | 101.8 | |
80.00 | 3.74 | 100.5 | 5.66 | 102.6 | |
17OHP | |||||
0.03 | 2.83 | 96.9 | 4.68 | 95.0 | |
0.25 | 3.51 | 95.2 | 4.80 | 96.3 | |
8.00 | 2.85 | 99.1 | 4.35 | 101.2 |
添加浓度/(ng/mL) | 批内 | 批间 | |||
---|---|---|---|---|---|
精密度(CV)/% | 准确度/% | 精密度(CV)/% | 准确度/% | ||
T | |||||
0.03 | 3.43 | 102.8 | 2.91 | 100.9 | |
0.25 | 4.12 | 101.1 | 3.64 | 100.7 | |
8.00 | 2.30 | 97.4 | 3.01 | 97.1 | |
DHT | |||||
0.06 | 2.92 | 101.9 | 3.56 | 100.5 | |
0.50 | 3.22 | 104.8 | 3.49 | 105.2 | |
16.00 | 2.53 | 100.4 | 2.87 | 102.4 | |
AD | |||||
0.03 | 2.62 | 99.2 | 4.47 | 99.6 | |
0.25 | 3.54 | 99.8 | 3.57 | 101.4 | |
8.00 | 2.59 | 104.2 | 2.97 | 102.3 | |
DHEA | |||||
0.30 | 4.75 | 101.8 | 4.75 | 98.2 | |
2.50 | 3.08 | 101.7 | 5.33 | 101.8 | |
80.00 | 3.74 | 100.5 | 5.66 | 102.6 | |
17OHP | |||||
0.03 | 2.83 | 96.9 | 4.68 | 95.0 | |
0.25 | 3.51 | 95.2 | 4.80 | 96.3 | |
8.00 | 2.85 | 99.1 | 4.35 | 101.2 |
项目 | 分析物基质效应 | 内标校正的基质效应 | 分析物提取回收率/% | 内标提取回收率/% |
---|---|---|---|---|
T | 0.669 2 | 0.945 3 | 60.5 | 63.5 |
DHT | 0.827 5 | 1.005 0 | 84.9 | 84.0 |
AD | 0.724 4 | 1.003 0 | 79.3 | 77.9 |
DHEA | 0.820 3 | 0.966 9 | 83.9 | 83.2 |
17OHP | 0.768 4 | 1.009 0 | 93.3 | 94.1 |
项目 | 分析物基质效应 | 内标校正的基质效应 | 分析物提取回收率/% | 内标提取回收率/% |
---|---|---|---|---|
T | 0.669 2 | 0.945 3 | 60.5 | 63.5 |
DHT | 0.827 5 | 1.005 0 | 84.9 | 84.0 |
AD | 0.724 4 | 1.003 0 | 79.3 | 77.9 |
DHEA | 0.820 3 | 0.966 9 | 83.9 | 83.2 |
17OHP | 0.768 4 | 1.009 0 | 93.3 | 94.1 |
项目 | 25 ℃ | -25~-15 ℃ | -90~-70 ℃ | |||||
---|---|---|---|---|---|---|---|---|
4 h | 24 h | 30 d | 100 d | 30 d | 100 d | |||
T | 0.76 | -2.81 | 8.89 | 0.57 | 8.75 | 0.68 | ||
DHT | 0.47 | -6.48 | -3.15 | -4.61 | -1.76 | 1.40 | ||
AD | 0.34 | -3.70 | 4.25 | 3.76 | 1.82 | 2.98 | ||
DHEA | -10.91 | -37.33 | -2.87 | -14.47 | -0.96 | -11.68 | ||
17OHP | -2.81 | 0.87 | 8.80 | 3.75 | 4.03 | 1.21 |
项目 | 25 ℃ | -25~-15 ℃ | -90~-70 ℃ | |||||
---|---|---|---|---|---|---|---|---|
4 h | 24 h | 30 d | 100 d | 30 d | 100 d | |||
T | 0.76 | -2.81 | 8.89 | 0.57 | 8.75 | 0.68 | ||
DHT | 0.47 | -6.48 | -3.15 | -4.61 | -1.76 | 1.40 | ||
AD | 0.34 | -3.70 | 4.25 | 3.76 | 1.82 | 2.98 | ||
DHEA | -10.91 | -37.33 | -2.87 | -14.47 | -0.96 | -11.68 | ||
17OHP | -2.81 | 0.87 | 8.80 | 3.75 | 4.03 | 1.21 |
项目 | 平均值/(nmol/L) | 靶值/(nmol/L) | 偏移/% | 评价范围/(nmol/L) | 2s | CV/% | 评价结果 |
---|---|---|---|---|---|---|---|
T | |||||||
201911 | 5.4 | 5.6 | -3.05 | 4.9~6.3 | 0.4 | 3.7 | 通过 |
201912 | 23.9 | 23.8 | 0.38 | 20.8~26.8 | 1.8 | 3.8 | 通过 |
17OHP | |||||||
201911 | 7.6 | 8.0 | -5.00 | 7.0~9.0 | 0.6 | 3.9 | 通过 |
201912 | 29.6 | 30.6 | -3.30 | 26.8~34.4 | 1.2 | 2.0 | 通过 |
项目 | 平均值/(nmol/L) | 靶值/(nmol/L) | 偏移/% | 评价范围/(nmol/L) | 2s | CV/% | 评价结果 |
---|---|---|---|---|---|---|---|
T | |||||||
201911 | 5.4 | 5.6 | -3.05 | 4.9~6.3 | 0.4 | 3.7 | 通过 |
201912 | 23.9 | 23.8 | 0.38 | 20.8~26.8 | 1.8 | 3.8 | 通过 |
17OHP | |||||||
201911 | 7.6 | 8.0 | -5.00 | 7.0~9.0 | 0.6 | 3.9 | 通过 |
201912 | 29.6 | 30.6 | -3.30 | 26.8~34.4 | 1.2 | 2.0 | 通过 |
组别 | 例数 | T/(ng/mL) | DHT/(ng/mL) | DHEA/(ng/mL) | AD/(ng/mL) | 17OHP/(ng/mL) |
---|---|---|---|---|---|---|
男性 | 120 | 4.78(3.93~5.84) | 0.30(0.22~0.36) | 3.50(2.44~5.30) | 0.89(0.70~1.11) | 0.99(0.78~1.23) |
16~20岁 | 20 | 4.49(3.75~6.13) | 0.25(0.19~0.33) | 3.29(2.33~5.68) | 0.90(0.67~1.14) | 1.08(0.79~1.60) |
21~30岁 | 20 | 5.38(4.34~6.75) | 0.26(0.24~0.41) | 5.72(4.45~6.75) | 0.99(0.85~1.26) | 1.01(0.86~1.42) |
31~40岁 | 20 | 4.50(0.86~1.42) | 0.30(0.23~0.37) | 3.68(2.41~5.30) | 0.89(0.70~1.23) | 0.83(0.62~1.24) |
41~50岁 | 20 | 4.84(3.77~5.67) | 0.30(0.21~0.42) | 3.50(2.72~4.20) | 0.72(0.65~1.02) | 0.86(0.72~1.20) |
51~60岁 | 20 | 4.78(3.88~5.84) | 0.31(0.26~0.41) | 3.30(2.58~4.71) | 0.93(0.71~1.50) | 1.00(0.84~1.05) |
>61岁 | 20 | 4.47(3.93~5.69) | 0.21(0.13~0.36) | 1.73(1.26~2.77) | 0.76(0.64~0.95) | 0.93(0.78~1.28) |
女性 | 247 | 0.20(0.12~0.28)* | 0.03(0.01~0.06)* | 3.00(1.36~5.68) | 0.74(0.45~1.20)* | 0.35(0.20~0.75)* |
16~20岁 | 20 | 0.27(0.22~0.32)*#△ | 0.06(0.04~0.09)*#△ | 5.82(4.06~7.76)*#△ | 1.11(0.97~1.36)*#△ | 0.50(0.33~1.00)*#△ |
21~30岁 | 37 | 0.33(0.24~0.41)*#△ | 0.07(0.05~0.10)*#△ | 6.68(4.84~9.25)*#△ | 1.38(1.27~1.81)*#△ | 0.58(0.37~1.67)*#△ |
31~40岁 | 33 | 0.26(0.22~0.34)*#△ | 0.05(0.03~0.08)*#△ | 5.24(3.25~7.81)*#△ | 1.22(0.94~1.43)*#△ | 0.56(0.30~1.55)*#△ |
41~50岁 | 33 | 0.20(0.16~0.28)*#△ | 0.04(0.00~0.06)*#△ | 3.60(2.78~5.42)*#△ | 0.89(0.74~1.13)*#△ | 0.62(0.26~1.24)*#△ |
51~60岁 | 28 | 0.12(0.10~0.17)*△ | 0.01(0.00~0.04)*△ | 2.59(1.48~3.70)*△ | 0.48(0.38~0.62)*△ | 0.20(0.14~0.37)*△ |
>61岁 | 96 | 0.13(0.08~0.21)* | 0.01(0.00~0.03)* | 1.24(0.56~2.21)* | 0.44(0.32~0.62)* | 0.24(0.12~0.40)* |
组别 | 例数 | T/(ng/mL) | DHT/(ng/mL) | DHEA/(ng/mL) | AD/(ng/mL) | 17OHP/(ng/mL) |
---|---|---|---|---|---|---|
男性 | 120 | 4.78(3.93~5.84) | 0.30(0.22~0.36) | 3.50(2.44~5.30) | 0.89(0.70~1.11) | 0.99(0.78~1.23) |
16~20岁 | 20 | 4.49(3.75~6.13) | 0.25(0.19~0.33) | 3.29(2.33~5.68) | 0.90(0.67~1.14) | 1.08(0.79~1.60) |
21~30岁 | 20 | 5.38(4.34~6.75) | 0.26(0.24~0.41) | 5.72(4.45~6.75) | 0.99(0.85~1.26) | 1.01(0.86~1.42) |
31~40岁 | 20 | 4.50(0.86~1.42) | 0.30(0.23~0.37) | 3.68(2.41~5.30) | 0.89(0.70~1.23) | 0.83(0.62~1.24) |
41~50岁 | 20 | 4.84(3.77~5.67) | 0.30(0.21~0.42) | 3.50(2.72~4.20) | 0.72(0.65~1.02) | 0.86(0.72~1.20) |
51~60岁 | 20 | 4.78(3.88~5.84) | 0.31(0.26~0.41) | 3.30(2.58~4.71) | 0.93(0.71~1.50) | 1.00(0.84~1.05) |
>61岁 | 20 | 4.47(3.93~5.69) | 0.21(0.13~0.36) | 1.73(1.26~2.77) | 0.76(0.64~0.95) | 0.93(0.78~1.28) |
女性 | 247 | 0.20(0.12~0.28)* | 0.03(0.01~0.06)* | 3.00(1.36~5.68) | 0.74(0.45~1.20)* | 0.35(0.20~0.75)* |
16~20岁 | 20 | 0.27(0.22~0.32)*#△ | 0.06(0.04~0.09)*#△ | 5.82(4.06~7.76)*#△ | 1.11(0.97~1.36)*#△ | 0.50(0.33~1.00)*#△ |
21~30岁 | 37 | 0.33(0.24~0.41)*#△ | 0.07(0.05~0.10)*#△ | 6.68(4.84~9.25)*#△ | 1.38(1.27~1.81)*#△ | 0.58(0.37~1.67)*#△ |
31~40岁 | 33 | 0.26(0.22~0.34)*#△ | 0.05(0.03~0.08)*#△ | 5.24(3.25~7.81)*#△ | 1.22(0.94~1.43)*#△ | 0.56(0.30~1.55)*#△ |
41~50岁 | 33 | 0.20(0.16~0.28)*#△ | 0.04(0.00~0.06)*#△ | 3.60(2.78~5.42)*#△ | 0.89(0.74~1.13)*#△ | 0.62(0.26~1.24)*#△ |
51~60岁 | 28 | 0.12(0.10~0.17)*△ | 0.01(0.00~0.04)*△ | 2.59(1.48~3.70)*△ | 0.48(0.38~0.62)*△ | 0.20(0.14~0.37)*△ |
>61岁 | 96 | 0.13(0.08~0.21)* | 0.01(0.00~0.03)* | 1.24(0.56~2.21)* | 0.44(0.32~0.62)* | 0.24(0.12~0.40)* |
人群 | 例数 | T/(ng/mL) | DHT/(ng/mL) | DHEA/(ng/mL) | AD/(ng/mL) | 17OHP/(ng/mL) |
---|---|---|---|---|---|---|
≥16岁男性 | 120 | 2.77~9.29 | 0.088~0.670 | 0.99~10.92 | 0.40~1.66 | 0.440~1.880 |
16~50岁女性 | 123 | 0.10~0.59 | 0.000~0.130 | 1.24~15.01 | 0.47~2.51 | 0.160~2.680 |
>50岁女性 | 124 | 0.04~0.37 | 0.000~0.086 | 0.00~5.89 | 0.13~0.96 | 0.029~0.850 |
人群 | 例数 | T/(ng/mL) | DHT/(ng/mL) | DHEA/(ng/mL) | AD/(ng/mL) | 17OHP/(ng/mL) |
---|---|---|---|---|---|---|
≥16岁男性 | 120 | 2.77~9.29 | 0.088~0.670 | 0.99~10.92 | 0.40~1.66 | 0.440~1.880 |
16~50岁女性 | 123 | 0.10~0.59 | 0.000~0.130 | 1.24~15.01 | 0.47~2.51 | 0.160~2.680 |
>50岁女性 | 124 | 0.04~0.37 | 0.000~0.086 | 0.00~5.89 | 0.13~0.96 | 0.029~0.850 |
[1] |
PUCKOWSKI A, MIODUSZEWSKA K, UKASZEWICZ P, et al. Bioaccumulation and analytics of pharmaceutical residues in the environment:a review[J]. J Pharm Biomed Anal, 2016, 127:232-255.
DOI URL |
[2] |
KUSHNIR M M, ROCKWOOD A L, ROBERTS W L, et al. Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories[J]. Clin Biochem, 2011, 44(1):77-88.
DOI URL |
[3] |
ZANG T, TAMAE D, MESAROS C, et al. Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry[J]. J Steroid Biochem Mol Biol, 2017, 165(Pt B):342-355.
DOI URL |
[4] |
YOO H S, NAPOLI J L. Quantification of dehydroepiandrosterone,17β-estradiol,testosterone,and their sulfates in mouse tissues by LC-MS/MS[J]. Anal Chem, 2019, 91(22):14624-14630.
DOI URL |
[5] |
MIURA N, MORI K, MOSTAFAEI H, et al. Prognostic value of testosterone for the castration-resistant prostate cancer patients:a systematic review and meta-analysis[J]. Int J Clin Oncol, 2020, 25(11):1881-1891.
DOI URL |
[6] | 肾上腺皮质癌诊治专家共识[J]. 现代泌尿外科杂志, 2021, 26(11):902-908. |
[7] | 曹正, 刘颖, 丛宇婷, 等. 多囊卵巢综合征相关雄性激素的液相色谱-串联质谱检测[J]. 分析测试学报, 2020, 39(1):146-151. |
[8] |
ORIOLO C, FANELLI F, CASTELLI S, et al. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone[J]. J Endocrinol Invest, 2020, 43(10):1499-1509.
DOI URL |
[9] |
ROSNER W, AUCHUS R J, AZZIZ R, et al. Position statement:utility,limitations,and pitfalls in measuring testosterone:an Endocrine Society position statement[J]. J Clin Endocrinol Metab, 2007, 92(2):405-413.
DOI URL |
[10] |
RAJKOWSKI K M, CITTANOVA N, URIOS P, et al. An enzyme-linked immunoassay of testosterone[J]. Steroids, 1977, 30(1):129-137.
DOI URL |
[11] |
ESCOBAR-MORREALE H F. Polycystic ovary syndrome:definition,aetiology,diagnosis and treatment[J]. Nat Rev Endocrinol, 2018, 14(5):270-284.
DOI URL |
[12] |
KAUFMANN A, BUTCHER P, MADEN K, et al. Determination of corticosteroids,anabolic steroids,and basic nonsteroidal anti-inflammatory drugs in milk and animal tissues[J]. J AOAC Int, 2014, 97(1):263-272.
DOI URL |
[13] |
LÓPEZ-GARCÍA M, ROMERO-GONZÁLEZ R, GARRIDO FRENICH A. Determination of steroid hormones and their metabolite in several types of meat samples by ultra high performance liquid chromatography-orbitrap high resolution mass spectrometry[J]. J Chromatogr A, 2018, 1540:21-30.
DOI URL |
[14] | 多囊卵巢综合征中国诊疗指南[J]. 中华妇产科杂志, 2018, 53(1):2-6. |
[15] | 刘琪. UPLC-MS/MS法定量分析类固醇激素及其在临床检测中的应用研究[D]. 武汉:中南民族大学, 2019. |
[16] | Clinical and Laboratory Standards Institute. Defining,establishing,and verifying reference intervals in the clinical laboratory[S]. EP28-A3C,CLSI, 2008. |
[17] | 龙琪琛, 张天娇, 闫颖, 等. 16种17-羟孕酮制备物基于两种评价方案的互通性研究[J]. 中华检验医学杂志, 2020, 43(1):44-50. |
[18] |
FANELLI F, BELLUOMO I, DI LALLO V D, et al. Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry:comparison with current immunoassays and reference intervals in healthy adults[J]. Steroids, 2011, 76(3):244-253.
DOI URL |
[1] | LI Xijiu, ZHOU Jianwei, ZHANG Qin, LONG Yunlin, WU Yingsong. Establishment and performance evaluation of UPLC-MS/MS for 6 markers in dried blood spots [J]. Laboratory Medicine, 2023, 38(5): 446-453. |
[2] | XU Weixin, CHEN Qing, DU Wenyong, GAO Yan. Plasma metabolic markers in patients with insomnia disorder [J]. Laboratory Medicine, 2023, 38(5): 454-459. |
[3] | WU Jie, LI Zenghe, CHEN Baorong, KONG Xujing. Establishment of traceable steroid hormone standard curve for dried blood spot samples [J]. Laboratory Medicine, 2023, 38(5): 489-493. |
[4] | Expert Group on the Consensus on Androgen Testing in Polycystic Ovary Syndrome China Association for Promotion of Health Science and Technology-Fertility Protection and Preservation Committee. Consensus on androgen testing in polycystic ovary syndrome [J]. Laboratory Medicine, 2023, 38(3): 203-208. |
[5] | YANG Xiaodong, LI Quanle, PAN Qingqing, ZHOU Jing, XIE Yangmin, ZOU Jihua, SHEN Min, ZHANG Man. Establishment and performance evaluation of candidate reference measurement procedure for the determination of immunosuppressive drugs in human whole blood by ID-LC-MS/MS [J]. Laboratory Medicine, 2023, 38(3): 215-222. |
[6] | WANG Yajie, ZU Bailing, GAN Chenxin, WU Jiaoxiang, SHU Jie, HANG Chen, CHEN Minghui, LIN Fujun, HU Zhigang, HUANG Biao, SHENG Huiming. Identification of plasma differential peptids in PLA2R1-related membranous nephropathy patients [J]. Laboratory Medicine, 2023, 38(3): 223-229. |
[7] | AN Yinghong, YAO Kechun, SU Chengming, TANG Jinhua, YANG Lixin, GAO Jie, XU Yanting, YAN Qiuhong, ZHAN Hongyan, MA Yueyun. Survey of serum homocysteine levels of apparently healthy subjects in Beijing [J]. Laboratory Medicine, 2023, 38(11): 1036-1040. |
[8] | ZHAO Yanhong, FU Lin, LIU Biao, XIAO Meifang. Reference interval of lactate dehydrogenase among 3-14-year-old population in Hainan [J]. Laboratory Medicine, 2023, 38(11): 1041-1043. |
[9] | HUANG Yuan, CHEN Feng, MAO Leili, ZHANG Linglin, LÜ Qian, YAN Jun, CUI Wei. Application of serum peptidomics based on MALDI-TOF MS in the differential diagnosis of benign and malignant pancreatic diseases [J]. Laboratory Medicine, 2023, 38(1): 1-7. |
[10] | XU Qianqian, JIANG Wangqing, SHEN Linjie, LU Yingjie, CHEN Jian, JIANG Haoqin. Establishment of the reference intervals for related parameters of adult reticulocytes in Shanghai [J]. Laboratory Medicine, 2022, 37(7): 641-645. |
[11] | TANG Ningbo, LIU Guancai, LIU Xiaoyu, YANG Fengfan, GONG Zhimei, SUN Keqi. Establishment and evaluation for the determination of serum digitoxin as a candidate reference method [J]. Laboratory Medicine, 2022, 37(5): 456-462. |
[12] | MIAO Linzi, LU Yao, QU Chenxue, YOU Ran, GONG Yan. Establishment of the reference intervals of leukocyte surface CD64 and HLA-DR indexes for healthy adults and related factors [J]. Laboratory Medicine, 2022, 37(3): 240-245. |
[13] | XU Runhao, ZOU Chen, CAO Yun, CHEN Feng, LIU Yijing, ZHANG Shulin, ZHANG Jie. Roles of serum amino acid determinations in the diagnosis of early non-small-cell lung cancer [J]. Laboratory Medicine, 2022, 37(12): 1157-1163. |
[14] | LIU Congcong, LI Jiaping, ZHOU Hongwei. Performance evaluation of 2 mass spectrometry systems in clinical microbial identification [J]. Laboratory Medicine, 2022, 37(11): 1084-1088. |
[15] | YANG Xi, SONG Wenqi, DONG Fang, MENG Qingying, ZHEN Jinghui, ZHOU Wei. Application of Gram staining and MALDI-TOF MS in the rapid identification of pathogen kinds in children's positive blood culture [J]. Laboratory Medicine, 2022, 37(10): 969-973. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||